MXPA02009449A - Ligandos dirigidos a la region no del eje del componente no secretor de la pigr y metodos de uso de los mismos. - Google Patents

Ligandos dirigidos a la region no del eje del componente no secretor de la pigr y metodos de uso de los mismos.

Info

Publication number
MXPA02009449A
MXPA02009449A MXPA02009449A MXPA02009449A MXPA02009449A MX PA02009449 A MXPA02009449 A MX PA02009449A MX PA02009449 A MXPA02009449 A MX PA02009449A MX PA02009449 A MXPA02009449 A MX PA02009449A MX PA02009449 A MXPA02009449 A MX PA02009449A
Authority
MX
Mexico
Prior art keywords
pigr
methods
stalk region
secretory component
ligands directed
Prior art date
Application number
MXPA02009449A
Other languages
English (en)
Inventor
Keith E Mostov
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of MXPA02009449A publication Critical patent/MXPA02009449A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
MXPA02009449A 2000-03-27 2001-03-26 Ligandos dirigidos a la region no del eje del componente no secretor de la pigr y metodos de uso de los mismos. MXPA02009449A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19219800P 2000-03-27 2000-03-27
US19219700P 2000-03-27 2000-03-27
PCT/US2001/009699 WO2001072846A2 (en) 2000-03-27 2001-03-26 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof

Publications (1)

Publication Number Publication Date
MXPA02009449A true MXPA02009449A (es) 2003-09-22

Family

ID=26887830

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02009449A MXPA02009449A (es) 2000-03-27 2001-03-26 Ligandos dirigidos a la region no del eje del componente no secretor de la pigr y metodos de uso de los mismos.

Country Status (8)

Country Link
US (2) US6855810B2 (es)
EP (1) EP1268555A2 (es)
JP (1) JP2003528891A (es)
AU (1) AU2001252970A1 (es)
CA (1) CA2404756A1 (es)
IL (1) IL151972A0 (es)
MX (1) MXPA02009449A (es)
WO (1) WO2001072846A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1328293B1 (en) 2000-05-10 2012-02-15 Signe BioPharma Inc. Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
US20030161809A1 (en) * 2000-10-02 2003-08-28 Houston L. L. Compositions and methods for the transport of biologically active agents across cellular barriers
US20030166160A1 (en) * 2001-09-06 2003-09-04 Hawley Stephen B. Compounds and molecular complexes comprising multiple binding regions directed to transcytotic ligands
AU2002343704A1 (en) * 2001-11-14 2003-05-26 David A. Sirbasku Screening method for predicting susceptibility to breast cancer
AU2004204763A1 (en) * 2003-01-09 2004-07-29 Arizeke Pharmaceuticals Inc. Compositions and methods for targeted biological delivery of molecular carriers
MXPA05007466A (es) * 2003-01-09 2006-03-08 Arizeke Pharmaceuticals Inc Metodos para el tratamiento de enfermedades pulmonares.
EP2322624B1 (en) 2005-03-25 2015-09-23 National Research Council Of Canada Method for isolation of soluble polypeptides
KR100958198B1 (ko) * 2008-06-18 2010-05-14 고려대학교 산학협력단 실시간 연속 검출장치
US8896679B2 (en) 2011-09-16 2014-11-25 The Invention Science Fund I, Llc Registering a region of interest of a body part to a landmark subsurface feature of the body part
CA3147916A1 (en) * 2019-08-02 2021-02-11 Janssen Biotech, Inc. Materials and methods for polymeric antibody receptor targeting
WO2022081460A1 (en) * 2020-10-12 2022-04-21 Janssen Biotech, Inc. Biosynthetic materials and methods for multidirectional biotransportation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2316148T3 (es) * 1994-03-23 2009-04-01 Ohio University Acidos nucleicos compactados y su suministro a celulas.
US6046037A (en) * 1994-12-30 2000-04-04 Hiatt; Andrew C. Method for producing immunoglobulins containing protection proteins in plants and their use
CN1183802A (zh) * 1994-12-30 1998-06-03 行星生物技术有限公司 在植物中生产含有保护性蛋白质的免疫球蛋白的方法和应用
AU728587B2 (en) 1996-06-04 2001-01-11 Regents Of The University Of California, The Cellular internalization of pIgR stalk and associated ligands
US6251392B1 (en) * 1997-10-20 2001-06-26 Epicyte Pharmaceuticals, Inc. Epithelial cell targeting agent

Also Published As

Publication number Publication date
US20050201932A1 (en) 2005-09-15
CA2404756A1 (en) 2001-10-04
AU2001252970A1 (en) 2001-10-08
WO2001072846A2 (en) 2001-10-04
WO2001072846A3 (en) 2002-04-04
EP1268555A2 (en) 2003-01-02
US20020102657A1 (en) 2002-08-01
US6855810B2 (en) 2005-02-15
US7404954B2 (en) 2008-07-29
JP2003528891A (ja) 2003-09-30
IL151972A0 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
ZA200300829B (en) The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands.
AP2004003034A0 (en) Antibodies to CD40.
HK1078266A1 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
HUP0302376A3 (en) Anti-tnf antibodies, compositions, methods and uses
NL300390I1 (en) Anti-IL-12 antibodies, compositions, methods and uses.
HUP0400375A3 (en) Composition containing fat oil and onion extract, the production and use thereof
HK1045630A1 (en) Soap-dispensing kitchen brush.
ZA200204020B (en) Use of anti-CTLA-4-antibodies.
MXPA03009390A (es) Anticuerpos para integrina vla-1.
MXPA03007319A (es) Anticuerpos contra egfr modificados, con inmunogenicidad reducida.
ZA200300068B (en) Catalyst and process for the preparation of hydrocarbons.
MXPA03004932A (es) 2-anilino-bencimidazoles sustituidos y su uso como inhibidores de nhe.
HK1048241A1 (en) Fryer.
MXPA03000488A (es) Composiciones para el lavado automatico de trastes en forma de gel, metodos de preparacion y uso de las mismas.
MXPA03007690A (es) Prenda absorbente y metodo para proporcionar la misma.
MXPA03009167A (es) PRODUCTO ABSORBENTE CON ADAPTACIoN MEJORADA.
EG23201A (en) Water filters and processes for using the same.
HK1043294A1 (en) Fryer.
MXPA02009449A (es) Ligandos dirigidos a la region no del eje del componente no secretor de la pigr y metodos de uso de los mismos.
MXPA03005065A (es) Bencil (indeno)-lactamas y su uso como ligandos del receptor 5-ht1.
AU2002359495A8 (en) Anti-tnf antibodies, compositions, methods and uses
HK1052380A1 (en) Utility lighter.
MXPA03009204A (es) PRODUCTO ABSORBENTE CON ADAPTACIoN MEJORADA.
HK1042025A1 (en) Fryer.
ZA200004865B (en) Heat transpiration preparation and method of the heat transpiration of chemical by using the same.

Legal Events

Date Code Title Description
FG Grant or registration